Data for Fig 1. by Rachael M. Giersch (22331947)

Subjects:

Molecular docking showed that ABT-199 can fit into active site of ALK^Mutant. by Richard Junior Zapata Dongo (17912565)

Subjects:

Amino acids interactions and binding energy describe that ABT-199 binds to ALK^Mutant. by Richard Junior Zapata Dongo (17912565)

Subjects:

The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

Subjects:

Anecdotal case of regression in a clam with naturally acquired BTN. by Rachael M. Giersch (22331947)

Subjects:

Negative (Prednisone) and basal (ATP) control compounds binding to ALK protein. by Richard Junior Zapata Dongo (17912565)

Subjects:

ALKG1202R –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

Subjects:

ALKC1156Y –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

Subjects:

ALKL1196M –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

Subjects:

ALK^wt–ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

Subjects:

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

Subjects:

Changepoint analysis in comparison of MarBTN-specific eDNA and cancer in hemolymph. by Rachael M. Giersch (22331947)

Subjects:

Multiple distinct outcomes observed in soft-shell clams (<i>Mya arenaria</i>) after natural infection with MarBTN. by Rachael M. Giersch (22331947)

Subjects:

Advancing Circular Bioeconomy through a Systems-Level Assessment of Food Waste and Industrial Sludge Codigestion by Md. Nizam Uddin (21632518)

Subjects:

MarBTN-specific eDNA detection in each clam that was followed for MarBTN in hemolymph and eDNA. by Rachael M. Giersch (22331947)

Subjects:

269 miRNAs of the 8 DSERGs. by Wei He (131453)

Subjects:

Comprehensive list of all SRGs. by Wei He (131453)

Subjects:

A total of 700 DEGs. by Wei He (131453)

Subjects:

The sagittal view of T2-weighted Magnetic Resonance Imaging represented a mild decrease in spinal cord diameter without any other lesions at first admission. by Hossein Pourmontaseri (19329565)

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. by Masashi Okawa (8951294)

Subjects: